IRCT20200105046010N61招募中未知
In- Vivo Bioequivalence study of Pirfenidone tablet 200 mg Arang Pharma with brand drug (PIRFENEX® 200mg, Cipla, India) in Iranian healthy volunteers.
Arang Pharm Co.0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •General health
- •Body mass index between18-28
- •Informed consent
- •Being at the age of 18-60 years old
排除标准
- •A history of cardiovascular disease
- •A history of liver & kidney disease
- •Alcohol & Drug addiction
- •Hypersensitivity to the drug
研究者
相似试验
尚未招募
不适用
Study of absorption and elimination rate of Pirfenidone 200-mg Tablets in comparison with Pirfenidone brand Tablets (Pirfenex®).Bioequivalence study.IRCT20200407046981N30Modava pharmaceutical company24
尚未招募
不适用
Bioequivalence study of Pirfenidone 267mgThis study is performed on healthy volunteers..IRCT20200623047902N3Zistdaru Danesh Company24
招募中
不适用
Eplerenone tablet 50mg Abourayhan (Alderon 50mg),In-Vivo Bioequivalence in iranian healthy volunteerIn this study the bioequivalence of test and brand of Esmoprazole will evaluated..IRCT20200105046010N2Aburayhan Pharmaceutical Co.24
已完成
不适用
Observational study of the effect of Pirfenidone on cough in patients with idiopathic pulmonary fibrosis.scarring of the lung10024967Idiopathic pulmonary fibrosisNL-OMON41593Erasmus MC, Universitair Medisch Centrum Rotterdam35
尚未招募
Unknown
sefulness of a new medicine -pirfenidone in oral fibrosis due to Arecanut and tobacco useCTRI/2023/04/051723Indian Council of Medical Research